Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry

The effectiveness and safety of biological disease-modifying antirheumatic drugs (bDMARDs) by age group (

Source: Arthritis Research and Therapy - June 8, 2020 Category: Rheumatology Authors: Akio Kawabe, Kazuhisa Nakano, Satoshi Kubo, Takeshi Asakawa and Yoshiya Tanaka Tags: Research article Source Type: research